HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Qian Selected Research

10-hydroxycamptothecin

1/2013Hepatic parenchymal changes following transcatheter embolization and chemoembolization in a rabbit tumor model.
11/2011Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model.
10/2010Experimental evaluation of inhibitory effect of 10-hydroxycamptothecin on hypoxia-inducible factor-1α expression and angiogenesis in liver tumors after transcatheter arterial embolization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Qian Research Topics

Disease

167Neoplasms (Cancer)
04/2022 - 10/2002
41Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2022 - 12/2005
33Neoplasm Metastasis (Metastasis)
04/2022 - 11/2005
18Breast Neoplasms (Breast Cancer)
01/2022 - 03/2011
17Glioma (Gliomas)
01/2021 - 07/2012
15Stomach Neoplasms (Stomach Cancer)
02/2022 - 12/2004
15Infections
01/2022 - 01/2009
14Lung Neoplasms (Lung Cancer)
01/2021 - 08/2006
14Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019 - 08/2004
13Carcinogenesis
10/2022 - 12/2005
12Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 10/2002
12Carcinoma (Carcinomatosis)
01/2019 - 03/2006
11Inflammation (Inflammations)
09/2022 - 07/2011
11Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 09/2009
11Myocardial Infarction
12/2021 - 07/2004
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 02/2013
10Glioblastoma (Glioblastoma Multiforme)
01/2021 - 08/2011
10Lymphatic Metastasis
01/2021 - 02/2013
10Hepatocellular Carcinoma (Hepatoma)
07/2019 - 01/2003
10Leukemia
01/2019 - 12/2004
9Colonic Neoplasms (Colon Cancer)
01/2022 - 03/2008
9Hypertension (High Blood Pressure)
02/2021 - 10/2010
8Asthma (Bronchial Asthma)
12/2021 - 03/2007
7Necrosis
01/2022 - 08/2011
7Wounds and Injuries (Trauma)
01/2022 - 10/2004
7Lymphoma (Lymphomas)
01/2022 - 12/2010
6Heart Failure
12/2021 - 12/2014
6Fibrosis (Cirrhosis)
07/2021 - 02/2007
6Brain Neoplasms (Brain Tumor)
01/2019 - 07/2011
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 12/2005
5Pain (Aches)
01/2022 - 10/2014
5Adenocarcinoma
01/2022 - 01/2009
5Hypoxia (Hypoxemia)
01/2020 - 10/2010
5Reperfusion Injury
01/2020 - 10/2004
5Cardiovascular Diseases (Cardiovascular Disease)
11/2015 - 02/2008
5Multiple Myeloma
01/2015 - 10/2009
5Chromosome Aberrations (Chromosome Abnormalities)
06/2013 - 06/2002
4Rectal Neoplasms (Rectal Cancer)
01/2022 - 10/2012
4Bacterial Infections (Bacterial Infection)
01/2022 - 07/2018
4Hemorrhage
02/2021 - 08/2013
4Thrombocytopenia (Thrombopenia)
02/2021 - 08/2004
4Acute Kidney Injury (Acute Renal Failure)
01/2021 - 03/2008
4Disease Progression
01/2018 - 03/2008
4Melanoma (Melanoma, Malignant)
04/2016 - 04/2010
3Urinary Bladder Neoplasms (Bladder Cancer)
08/2022 - 11/2018

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2005
30Biomarkers (Surrogate Marker)IBA
02/2022 - 03/2008
21MicroRNAs (MicroRNA)IBA
06/2022 - 08/2011
21Pharmaceutical PreparationsIBA
01/2022 - 10/2002
16Messenger RNA (mRNA)IBA
02/2022 - 10/2004
14Long Noncoding RNAIBA
06/2022 - 01/2015
9Biological ProductsIBA
04/2022 - 04/2014
8CytokinesIBA
10/2022 - 01/2014
8Therapeutic UsesIBA
01/2021 - 01/2003
8AntigensIBA
01/2019 - 12/2004
7RNA (Ribonucleic Acid)IBA
01/2022 - 08/2004
7Peptides (Polypeptides)IBA
01/2020 - 10/2007
7IntegrinsIBA
01/2019 - 03/2008
6EnzymesIBA
01/2022 - 06/2012
6Indicators and Reagents (Reagents)IBA
01/2021 - 01/2016
6GoldIBA
12/2020 - 02/2010
6Interferon Type IIBA
07/2017 - 12/2012
5Glucose (Dextrose)FDA LinkGeneric
12/2020 - 09/2009
5Cadherins (E-Cadherin)IBA
01/2020 - 10/2016
5Small Interfering RNA (siRNA)IBA
01/2019 - 03/2012
5Cytarabine (Cytosar-U)FDA LinkGeneric
07/2017 - 06/2010
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 08/2010
5LigandsIBA
12/2015 - 06/2007
5Complementary DNA (cDNA)IBA
10/2011 - 09/2003
4tanshinoneIBA
04/2022 - 11/2015
4Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 07/2015
4CreatinineIBA
05/2021 - 03/2008
4LuciferasesIBA
01/2021 - 01/2019
4Temozolomide (Temodar)FDA LinkGeneric
01/2021 - 03/2013
4omega-Chloroacetophenone (Mace)IBA
12/2020 - 02/2008
4Liposomes (Liposome)IBA
11/2020 - 11/2015
4Silicon Dioxide (Silica)FDA LinkGeneric
12/2019 - 11/2008
4GlucocorticoidsIBA
11/2019 - 01/2015
4DecitabineFDA Link
01/2019 - 06/2017
4Phosphotransferases (Kinase)IBA
01/2019 - 08/2013
4Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2019 - 01/2003
4ErbB Receptors (EGF Receptor)IBA
01/2019 - 03/2013
4Rituximab (Mabthera)FDA Link
01/2018 - 11/2014
4Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 06/2012
4Glutathione PeroxidaseIBA
01/2015 - 01/2015
4Capsules (Microcapsules)IBA
02/2014 - 03/2008
4Transferrin (beta 2 Transferrin)IBA
03/2010 - 03/2007
3Circular RNAIBA
02/2022 - 04/2017

Therapy/Procedure

55Therapeutics
02/2022 - 01/2003
25Drug Therapy (Chemotherapy)
01/2022 - 12/2004
9Lasers (Laser)
01/2022 - 01/2005
6Length of Stay
01/2022 - 08/2013
6Transplantation
06/2021 - 07/2004
5Photothermal Therapy
02/2022 - 09/2016
5Stents
01/2022 - 02/2008
5Radiotherapy
01/2019 - 05/2013
4Precision Medicine
02/2022 - 09/2016
4Catheters
01/2022 - 08/2011
4Immunotherapy
01/2021 - 03/2014
4Denervation
01/2019 - 05/2013